Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$16.0 - $45.99 $84,160 - $241,907
-5,260 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$39.06 - $67.58 $205,455 - $355,470
5,260 New
5,260 $226,000
Q3 2021

Nov 09, 2021

SELL
$60.13 - $77.6 $192,716 - $248,707
-3,205 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$50.07 - $76.78 $500 - $767
-10 Reduced 0.31%
3,205 $235,000
Q1 2021

May 05, 2021

SELL
$58.92 - $97.33 $3,535 - $5,839
-60 Reduced 1.83%
3,215 $221,000
Q4 2020

Feb 09, 2021

BUY
$43.6 - $73.05 $142,790 - $239,238
3,275 New
3,275 $220,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $743M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.